Increase in oral cancer drugs raises thorny issues for oncology practices.
Hede
Karyn
K
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000191:economics*; D019317:Evidence-Based Medicine; D006801:Humans; D007196:Indiana; D007262:Infusions, Intravenous / Q000191:economics; D019458:Insurance Coverage; D007391:International Cooperation; D016347:Medical Records Systems, Computerized; D006278:Medicare; D055118:Medication Adherence; D008508:Medication Errors; D009062:Mouth Neoplasms / Q000188:drug therapy* / Q000191:economics; D009922:Oregon; D010353:Patient Education as Topic; D010818:Practice Patterns, Physicians' / Q000191:economics / Q000331:legislation & jurisprudence / Q000458:organization & administration / Q000592:standards / Q000639:trends; D014481:United States
D000970:Antineoplastic Agents